Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In integrative veterinary medicine, I use BPC-157 as an advanced, root-cause support for pets with chronic gut issues, skin flares, inflammatory conditions, or slow healing
Separately, in a Federal Register notice published May 1, 2026 (docket FDA-2018-N-3240), FDA proposed NOT to add semaglutide, tirzepatide, or liraglutide to the 503B outsourcing-facility bulks list
[PMID: 37348874] PubMed record related to this compound for laboratory literature review
But TB-500 as sold in grey markets is not the same thing as a well-characterized pharmaceutical product, and the FDAs Category 2 listing includes Thymosin Beta-4, Fragment (LKKTETQ) as a substance raising significant safety risks in compounding contexts
No human clinical trials have been published
US$ 28.51
US$ 22.34
US$ 26.71
US$ 23.83
